Curtis A Lachowiez
OHSU Knight Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Curtis A Lachowiez as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:26 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07844694 · Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet DisorderOHSU Knight Cancer Institute · recruiting · Familial Platelet Disorder With Associated Myeloid Malignancy · principal investigator
- Ph2NCT07228273 · Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid LeukemiaOHSU Knight Cancer Institute · recruiting · Acute Myeloid Leukemia, Myelodysplastic Syndrome · principal investigator
- Ph2NCT06504459 · Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AMLOHSU Knight Cancer Institute · recruiting · Acute Monocytic Leukemia, Acute Myeloid Leukemia · principal investigator
- Ph1NCT06357182 · Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid LeukemiaOHSU Knight Cancer Institute · recruiting · Acute Myeloid Leukemia, Myelodysplastic Syndrome/Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center AdministrationP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Mindy Roberts · fiscal years 1997 to 2026Named on NCT07844694
Most cited trial papers
Clinical-trial papers with this author name in acute myeloid leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 11:26 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia.J Clin Oncol · 2021297 citationsRCR 16.3
- Venetoclax combined with induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia: a post-hoc, propensity score-matched, cohort study.Lancet Haematol · 202261 citationsRCR 4.0